Sign in with Google
bullish
US Hidden Gems | Avid Bioservices: Transitioning Avidly to Pure-Play Biologics CDMO
396 Views20 Aug 2020 00:59
Avid Bioservices Inc (CDMO US) (“Avid”) is a $480mm market-cap US based pure-play biologics CDMO (Contract Development & Manufacturing...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 18-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Yuanta/P-Shares Taiwan Div+ ETF Rebalance: Huge Turnover & Flow Overlap
- NIFTY200 Momentum30 Index Rebalance: HUGE Turnover and Trade as Financials Shine
- Merger Arb Mondays (09 June) - Mayne, Tam Jai, OneConnect, Toyota Industries, Makino, Fuji Corp
- [Japan M&A] Private Co Takeout of Fuji Corp (7605 JP) - A Done Deal
- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
Top Unpaywalled Insights
More »- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Avid Bioservices | Up ~2x in 7 Months - Since We Initiated Coverage; Highest Ever Order Backlog10 Mar 2021
- Avid Bioservices: Strong Quarterly Performance Led to 25%+ Re-Rating Last Week. More to Go.07 Dec 2020
- Avid Bioservices: Reports Largest Quarterly Profit Ever; Robust Guidance and Attractive Valuation05 Sep 2020
- Lonza: A Bellwether Biopharma Focused CDMO | At Inflection Point, To Benefit from Ongoing Capex17 Jul 2020
- Wuxi Biologics Placement: Another Pre-Lockup Placement but Past Deals Have Done Well31 Mar 2020
x